Category:
Tracking the Scientific Literature on SARS-CoV-2 Variants Using the COVID-19 Genomics and Precision Health Knowledge Base
![a stack of journals with the COVID-19 GPH logo in the background](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2021/07/2021-7_COVID_pub-1.jpg)
The first reports of SARS-CoV-2, the highly infectious virus causing COVID-19, swept across the globe in December 2019, prompting a burst of scientific activity. The rate of research and discovery intensified as the pandemic grew, resulting in a flood of publications in journals and on preprint servers around the world. More recently, SARS-CoV-2 variants have Read More >
Posted on by 1 CommentMendelian Randomization: A Precision Public Health Tool for the COVID-19 Response
![flowchart: Confounder arrows to Modifiable Exposure and Disease Outcome; Gene Variant (Instrument Exposure Variable) arrow to Modifiable Exposure and Modifiable Exposure arrow to Disease Outcome](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2021/07/2021_7_blog_mendelia1-1.jpg)
In the early days of the COVID-19 pandemic, when little was known about the natural history of the disease, predicting the course of the pandemic was of premier importance for treating sick patients and redoubling efforts to protect those at highest risk of adverse outcomes. To address this need, investigators used a study design that Read More >
Posted on by